Phosphorylation of the β-Amyloid Precursor Protein at the Cell Surface by Ectocasein Kinases 1 and 2*
暂无分享,去创建一个
[1] B. Nilsson,et al. Alterations in C3 activation and binding caused by phosphorylation by a casein kinase released from activated human platelets. , 1999, Journal of immunology.
[2] P. Greengard,et al. Role of Phosphorylation of Alzheimer’s Amyloid Precursor Protein during Neuronal Differentiation , 1999, The Journal of Neuroscience.
[3] Sarah Tomlin,et al. Microtechnology: Laying it on thick , 1999, Nature.
[4] Wei Li,et al. Heparin-induced Conformational Change in Microtubule-associated Protein Tau as Detected by Chemical Cross-linking and Phosphopeptide Mapping* , 1999, The Journal of Biological Chemistry.
[5] C. Haass,et al. Phosphorylation of presenilin-2 regulates its cleavage by caspases and retards progression of apoptosis. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[6] R. Paro,et al. Transgenic Drosophila expressing human amyloid precursor protein show gamma-secretase activity and a blistered-wing phenotype. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[7] M. Goedert,et al. Effect of heparin on phosphorylation site specificity of neuronal Cdc2‐like kinase , 1998, FEBS letters.
[8] Masato Hasegawa,et al. Alzheimer-like Changes in Microtubule-associated Protein Tau Induced by Sulfated Glycosaminoglycans , 1997, The Journal of Biological Chemistry.
[9] M. Mattson. Cellular actions of beta-amyloid precursor protein and its soluble and fibrillogenic derivatives. , 1997, Physiological reviews.
[10] D. Selkoe,et al. Ectodomain Phosphorylation of β-Amyloid Precursor Protein at Two Distinct Cellular Locations* , 1997, The Journal of Biological Chemistry.
[11] C. Masters,et al. Secreted Glypican Binds to the Amyloid Precursor Protein of Alzheimer's Disease (APP) and Inhibits APP-induced Neurite Outgrowth* , 1996, The Journal of Biological Chemistry.
[12] R. Crowther,et al. Assembly of microtubule-associated protein tau into Alzheimer-like filaments induced by sulphated glycosaminoglycans , 1996, Nature.
[13] M. V. Hogan,et al. Surface protein phosphorylation by ecto-protein kinase is required for the maintenance of hippocampal long-term potentiation. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[14] D. Selkoe,et al. Amyloid β-Protein and the Genetics of Alzheimer's Disease* , 1996, The Journal of Biological Chemistry.
[15] V. Kinzel,et al. Induced Release of Cell Surface Protein Kinase Yields CK1- and CK2-like Enzymes in Tandem (*) , 1996, The Journal of Biological Chemistry.
[16] M. V. Hogan,et al. Surface Phosphorylation by Ecto‐Protein Kinase C in Brain Neurons: A Target for Alzheimer's β‐Amyloid Peptides , 1995, Journal of neurochemistry.
[17] J. Higaki,et al. Inhibition of β-amyloid formation identifies proteolytic precursors and subcellular site of catabolism , 1995, Neuron.
[18] D. Selkoe,et al. Polarized sorting of beta-amyloid precursor protein and its proteolytic products in MDCK cells is regulated by two independent signals , 1995, The Journal of cell biology.
[19] Z. Fishelson,et al. Shedding of tyrosine and serine/threonine ecto-protein kinases from human leukemic cells. , 1995, Archives of biochemistry and biophysics.
[20] K. Muramoto,et al. A substrate of ecto-protein kinase is microtubule-associated protein 1B in cortical cell cultures undergoing synaptogenesis. , 1994, Biochemical and biophysical research communications.
[21] M. Ciotti,et al. Identification of an Ectokinase Activity in Cerebellar Granule Primary Neuronal Cultures , 1994, Journal of neurochemistry.
[22] S. Squazzo,et al. Evidence that production and release of amyloid beta-protein involves the endocytic pathway. , 1994, The Journal of biological chemistry.
[23] K. Mann,et al. Platelet coagulation factor Va: the major secretory platelet phosphoprotein. , 1994, Blood.
[24] D. Small,et al. A heparin-binding domain in the amyloid protein precursor of Alzheimer's disease is involved in the regulation of neurite outgrowth , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[25] P. Greengard,et al. Cell cycle‐dependent regulation of the phosphorylation and metabolism of the Alzheimer amyloid precursor protein. , 1994, The EMBO journal.
[26] D. Selkoe,et al. Selective ectodomain phosphorylation and regulated cleavage of beta‐amyloid precursor protein. , 1994, The EMBO journal.
[27] D. Selkoe,et al. Cellular processing of β-amyloid precursor protein and the genesis of amyloid β-peptide , 1993, Cell.
[28] P. Greengard,et al. Serine phosphorylation of the secreted extracellular domain of APP. , 1993, Biochemical and biophysical research communications.
[29] P. Ekman,et al. Endothelial cells release casein kinase II--like activity capable of phosphorylating fibrinogen in response to thrombin. , 1993, Thrombosis research.
[30] G. Dubyak,et al. Signal transduction via P2-purinergic receptors for extracellular ATP and other nucleotides. , 1993, The American journal of physiology.
[31] B. Strooper,et al. Study of the synthesis and secretion of normal and artificial mutants of murine amyloid precursor protein (APP): cleavage of APP occurs in a late compartment of the default secretion pathway , 1993, The Journal of cell biology.
[32] P. Matsudaira,et al. Generation of beta-amyloid in the secretory pathway in neuronal and nonneuronal cells. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[33] L. Thal,et al. Secretion of β-amyloid precursor protein cleaved at the amino terminus of the β-amyloid peptide , 1993, Nature.
[34] S. Estus,et al. Production of the Alzheimer amyloid beta protein by normal proteolytic processing. , 1992, Science.
[35] D. Selkoe,et al. Amyloid β-peptide is produced by cultured cells during normal metabolism , 1992, Nature.
[36] J. Schrader,et al. Exo-protein kinase release from intact cultured aortic endothelial cells. , 1992, Biochimica et biophysica acta.
[37] S. Wagner,et al. High level expression, purification, and characterization of the Kunitz-type protease inhibitor domain of protease nexin-2/amyloid β-protein precursor , 1992 .
[38] S. Sisodia. Beta-amyloid precursor protein cleavage by a membrane-bound protease. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[39] D. Selkoe,et al. Targeting of cell-surface β-amyloid precursor protein to lysosomes: alternative processing into amyloid-bearing fragments , 1992, Nature.
[40] D. Selkoe,et al. Processing of the amyloid protein precursor to potentially amyloidogenic derivatives. , 1992, Science.
[41] D. Selkoe,et al. Processing of beta-amyloid precursor protein in microglia and astrocytes favors an internal localization over constitutive secretion , 1991, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[42] S. Nakanishi,et al. Inhibition of nerve growth factor‐induced neurite outgrowth of PC12 cells by a protein kinase inhibitor which does not permeate the cell membrane , 1991, FEBS letters.
[43] H. Coste,et al. The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C. , 1991, The Journal of biological chemistry.
[44] K. Skubitz,et al. Characterization of human neutrophil ecto-protein kinase activity released by kinase substrates. , 1991, Journal of immunology.
[45] U. Naik,et al. Phosphorylation and dephosphorylation of human platelet surface proteins by an ecto-protein kinase/phosphatase system. , 1991, Biochimica et biophysica acta.
[46] C. Masters,et al. Synthesis and secretion of Alzheimer amyloid βA4 precursor protein by stimulated human peripheral blood leucocytes , 1990, FEBS letters.
[47] R. Martins,et al. The amyloid precursor protein of Alzheimer's disease is released by human platelets. , 1990, The Journal of biological chemistry.
[48] G. Broze,et al. Platelet coagulation factor XIa-inhibitor, a form of Alzheimer amyloid precursor protein. , 1990, Science.
[49] M. Hagiwara,et al. Inhibition of forskolin-induced neurite outgrowth and protein phosphorylation by a newly synthesized selective inhibitor of cyclic AMP-dependent protein kinase, N-[2-(p-bromocinnamylamino)ethyl]-5-isoquinolinesulfonamide (H-89), of PC12D pheochromocytoma cells. , 1990, The Journal of biological chemistry.
[50] H. Tokumitsu,et al. KN-62, 1-[N,O-bis(5-isoquinolinesulfonyl)-N-methyl-L-tyrosyl]-4-phenylpiperazi ne, a specific inhibitor of Ca2+/calmodulin-dependent protein kinase II. , 1990, The Journal of biological chemistry.
[51] G. Cole,et al. The regulation of amyloid β protein precursor secretion and its modulatory role in cell adhesion , 1989, Neuron.
[52] V. Kinzel,et al. Evidence for ecto-protein kinase activity that phosphorylates Kemptide in a cyclic AMP-dependent mode. , 1989, The Journal of biological chemistry.
[53] Andreas Weidemann,et al. Identification, biogenesis, and localization of precursors of Alzheimer's disease A4 amyloid protein , 1989, Cell.
[54] M. Hagiwara,et al. A newly synthesized selective casein kinase I inhibitor, N-(2-aminoethyl)-5-chloroisoquinoline-8-sulfonamide, and affinity purification of casein kinase I from bovine testis. , 1989, The Journal of biological chemistry.
[55] K. Grzeschik,et al. The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor , 1987, Nature.
[56] E. Bock,et al. Ecto-protein kinase activity on the external surface of neural cells , 1986, Nature.
[57] J. L. Gordon. Extracellular ATP: effects, sources and fate. , 1986, The Biochemical journal.
[58] C. Masters,et al. Amyloid plaque core protein in Alzheimer disease and Down syndrome. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[59] R. Weinmann,et al. Inhibitory effect of 5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole on a protein kinase. , 1984, The Journal of biological chemistry.
[60] V. Kinzel,et al. Substrate-effected release of surface-located protein kinase from intact cells. , 1983, Proceedings of the National Academy of Sciences of the United States of America.
[61] V. Kinzel,et al. Protein kinase activity and substrates at the surface of intact HeLa cells. , 1982, The Journal of biological chemistry.
[62] G. Glenner,et al. Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. 1984. , 2012, Biochemical and biophysical research communications.
[63] H. Braak,et al. Neuropathological stageing of Alzheimer-related changes , 2004, Acta Neuropathologica.
[64] L Meijer,et al. Inhibition of cyclin-dependent kinases, GSK-3beta and CK1 by hymenialdisine, a marine sponge constituent. , 2000, Chemistry & biology.
[65] D. Price,et al. Mutant genes in familial Alzheimer's disease and transgenic models. , 1998, Annual review of neuroscience.
[66] L Meijer,et al. Biochemical and cellular effects of roscovitine, a potent and selective inhibitor of the cyclin-dependent kinases cdc2, cdk2 and cdk5. , 1997, European journal of biochemistry.
[67] G. Multhaup. Identification and regulation of the high affinity binding site of the Alzheimer's disease amyloid protein precursor (APP) to glycosaminoglycans. , 1994, Biochimie.
[68] R. Pearson,et al. Protein kinase phosphorylation site sequences and consensus specificity motifs: tabulations. , 1991, Methods in enzymology.
[69] Huang Kp,et al. Purification and analysis of protein kinase C isozymes. , 1991 .